IL-6 can be considered an early biomarker in the prediction of clinical deterioration of patients with moderate-to-severe COVID-19, especially when associated with other biochemical and physiological parameters such as SpO2/FiO2 ratio and C-reactive protein itself [43]. Here, IL6 is linked to COVID-19.